Diabetes 1996
Huyghe JR, et al
The risk-benefit discussion should include GI intolerance, dehydration/renal risk, gallbladder disease, pancreatitis warning symptoms, diabetic retinopathy monitoring in some patients, hypoglycemia risk when combined with insulin/sulfonylureas, and the thyroid C-cell tumor contraindication context
Most patient reports describe migraine onset within the first two to four weeks of starting semaglutide, often coinciding with dose escalation phases
Managing retatrutide side effects While we wait for retatrutide to complete its clinical programme and potentially gain approval, the management strategies are likely to mirror what works well for existing GLP-1 medications: For nausea and GI symptoms: Eat smaller portions more frequently rather than large meals Avoid fatty, greasy or heavily spiced food, particularly during dose-escalation weeks Eat slowly and stop when you feel comfortable not full Stay upright after eating
At MedSpa of DFW, we understand that successful weight loss requires more than just medication